China Data Law Update: Certification Rules and Draft Standard Contract Are Issued
As the year approaches its halfway point, Chinese government accelerates the legislation for cross-border data transfers.
Understanding China’s Data Regulatory Regime: China Solicits Public Comments on Certification Rules for Cross-Border Data Processing Activities
Certification by a professional institution is one of the mechanisms permitted under China’s Personal Information Protection Law (PIPL) to legitimize cross-border transfers of personal information. Other permitted mechanisms include governmental security review and standard contractual clauses to be issued by the Chinese government. However, to date, there have … Read More
Understanding China’s Data Regulatory Regime: What Are Important Data? And Can They Be Transferred Outside Of China?
The concept of “important data” is a cornerstone of China’s data regulatory regime. The Cyber Security Law (2017) (the CSL) prohibits operators of critical information infrastructures (CIIs) from transferring their “important data” and personal information outside of China. The Data Security Law (2021) (the DSL) and … Read More
Trump Executive Order Blocks Transactions With Certain Chinese Software Applications
On January 5, 2021, President Donald Trump signed Executive Order (EO) 13971, banning certain transactions and activities with persons who “develop or control” eight Chinese “connected software applications,”1 specifically Alipay, CamScanner, QQ Wallet, SHAREit, Tencent QQ, VMate, WeChat Pay, and WPS Office. The prohibitions will come into effect 45 … Read More
China Food and Drug Administration Announces Penalties for Clinical Trial Data Integrity Violations
On May 24, 2017, the China Food and Drug Administration (CFDA) issued its [2017] Circular No. 63 (the Circular), setting out penalties for clinical trial data integrity violations, including intentional data falsification, incomplete and incompliant data and other data defects. The highlights are: